E ENCOMPASS HEALTH CORP
| Market Cap | $9.80B |
| P/E Ratio | 17.55 |
| Forward P/E | 15.04 |
| Dividend Yield | 0.78% |
| Beta | 0.60 |
| 52W Range | $93.65 - $126.70 |
| # Hedge Funds | 1 |
| Sector | Healthcare |
| Industry | Medical Care Facilities |
Hedge Fund Ownership
| Investor 1 | % of Portfolio Weight of this stock in the investor's portfolio | Value Total dollar value of the position | Shares Number of shares held | Activity Portfolio change type: New, Increased, Decreased, or Sold |
|---|---|---|---|---|
| Jensen Investment Management Jensen Investment Management | 0.08% | $5.38M | 50,660 | — |
Insider Trading
| Insider Name of the company insider who made the trade 10 | Type Purchase (buy) or Sale (sell) | Shares Number of shares traded | Price Price per share at time of transaction | Value Total dollar value of the transaction | Trade Date Date the transaction was executed | Filing Date Date the SEC filing was submitted |
|---|---|---|---|---|---|---|
| Fay EdmundSr. Vice Pres. and Treasurer | Sale | 11,937 | $107.00 | $1.28M | 09 Mar 2026 | 09 Mar 2026 |
| Tarr Mark JPresident & CEO | Sale | 87,745 | $113.09 | $9.92M | 11 Feb 2026 | 12 Feb 2026 |
| Tarr Mark JPresident & CEO | Sale | 6,057 | $111.89 | $677.72K | 11 Feb 2026 | 12 Feb 2026 |
| Tarr Mark JPresident & CEO | Sale | 15,584 | $110.07 | $1.72M | 11 Feb 2026 | 12 Feb 2026 |
| Tarr Mark JPresident & CEO | Sale | 13,231 | $108.80 | $1.44M | 11 Feb 2026 | 12 Feb 2026 |
| Tarr Mark JPresident & CEO | Sale | 16,216 | $108.03 | $1.75M | 11 Feb 2026 | 12 Feb 2026 |
| Tarr Mark JPresident & CEO | Sale | 213 | $113.58 | $24.19K | 11 Feb 2026 | 12 Feb 2026 |
| Tarr Mark JPresident & CEO | Sale | 10,954 | $110.92 | $1.22M | 11 Feb 2026 | 12 Feb 2026 |
| Tuer Patrick WilliamEVP, Chief Operating Officer | Sale | 2,804 | $107.62 | $301.77K | 10 Feb 2026 | 10 Feb 2026 |
| Patrick William TuerEVP, Chief Operating Officer | Sale | 2,804 | $107.62 | $301.77K | 10 Feb 2026 | 10 Feb 2026 |
Frequently Asked Questions
What is EHC stock price today?
ENCOMPASS HEALTH CORP (EHC) is currently trading at $97.39. The stock has a 52-week range of $93.65 to $126.70 and a market capitalization of $9.80B.
Is EHC a good stock to buy in 2026?
ENCOMPASS HEALTH CORP has a P/E ratio of 17.5 (forward P/E: 15.0), a dividend yield of 0.78%, and 1-year performance of -3.8%. 1 hedge funds hold this stock. Review the fundamentals and ownership data above to make an informed decision.
Are insiders buying or selling EHC stock?
There have been 10 insider transactions for EHC in recent months. Insider buys can signal management confidence, while sales may reflect diversification or personal financial planning. Check the Insider Trading section above for details.
How has EHC stock performed over the past year?
ENCOMPASS HEALTH CORP (EHC) has returned -3.8% over the past 12 months. The stock traded between $93.65 and $126.70 during this period, and is currently at $97.39.
Which hedge funds own EHC (ENCOMPASS HEALTH CORP)?
1 tracked hedge funds currently hold EHC in their portfolios as of the latest 13F filings. See the ownership table above for the complete list.
What is EHC's market cap and valuation?
ENCOMPASS HEALTH CORP (EHC) has a market capitalization of $9.80B. The trailing P/E ratio is 17.5 and forward P/E is 15.0. The stock is classified in the Healthcare sector.
What is EHC's revenue and profitability?
ENCOMPASS HEALTH CORP reported revenue of $5.94B with net income of $565.70M and a profit margin of 0.10%. The stock has a beta of 0.60.
What sector is EHC in and who are its biggest institutional holders?
ENCOMPASS HEALTH CORP (EHC) operates in the Healthcare sector. It is held by 1 tracked hedge funds. See the ownership table above for the complete list.